Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer

Clinical trial NCT03340376 · UNKNOWN

Trial details

NCT number: NCT03340376
Sponsor: Universitaire Ziekenhuizen KU Leuven
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer

Start date: 2017-08-30
Primary completion: 2025-09-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.